Latest Manufacturing Operations News

Reliance Worldwide Corporation plans to shutter its brass manufacturing in Melbourne, citing declining volumes tied to automation and supply chain shifts, while targeting a US$9 million boost to operating earnings by FY27.

IperionX has acquired Covia’s Camden mineral assets adjacent to its Titan Project, consolidating a key U.S. critical minerals province and enhancing its supply chain for heavy rare earths and titanium.

Lithium Energy is selling its Queensland graphite projects for $20 million to M Battery Materials, which plans an ASX listing focused on battery minerals. Shareholders may receive MBM shares in-specie, gaining direct exposure to a growing battery materials platform.

Zimi Limited posted 14% revenue growth and landed its biggest project order to date with Homecorp, while slashing operating costs and launching an AI sales agent.

DGL Group reported a 5.8% revenue decline to $225.2 million in H1 FY26, weighed down by audit qualifications, ERP rollout delays, and one-off impairments. Despite these headwinds, the company cut net debt by $16.4 million and advanced strategic site consolidations and new facility investments.

Orora has lowered its FY26 EBIT forecast for its Saverglass business due to direct operational impacts and indirect market shifts stemming from the ongoing Middle East conflict, while maintaining stable guidance for other segments.

Delorean Corporation has approved the Final Investment Decision for its 100% owned NSW1 Horsley Park Bioenergy Facility, supported by $30.5 million in grants. Construction is planned to start in Q3 2026, pending the securing of $31.6 million in additional funding.

Peak Processing Limited anticipates a surge in beverage production to approximately 1.4 million units in Q4 FY26, driven by strong customer demand and operational improvements. The company also reports near-perfect delivery performance and multiple new product listings with the Ontario Cannabis Store.

Peak Processing Limited reported a sharp 47.7% revenue drop and a 257.7% increase in losses for H1 2026, alongside a significant asset impairment and ongoing going concern concerns.

SDI Limited reported a modest 2% dip in net profit for H1 FY26 despite a 2.7% rise in sales, driven by growth in aesthetics and exports. The company faces challenges from regulatory bans on Amalgam products while advancing plans for manufacturing upgrades and a potential acquisition.

Star Combo Pharma reported a 23% decline in revenue to $11.9 million for the half year ended December 2025, driven by the loss of a major OEM contract and closure of its AustoYou retail business. Despite this, operating profit after tax rose 49% to $413,243, reflecting effective cost management.

thl reports an 11% rise in underlying NPAT for H1 FY26 and sets a bullish FY26 guidance, underpinned by strategic divestments and cost efficiencies.